Tesamorelin (10mg)

GHRH Analog (Smaller Research Vial)

Tesamorelin (10mg) will be supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

Tesamorelin is a stabilised analog of growth hormone-releasing hormone (GHRH). Research interest centres on its preferential effect on visceral adipose tissue (VAT) rather than general weight reduction — making it distinct from GLP-1-class compounds. It is one of the most studied GHRH-class peptides for body composition research.

The 10mg format suits shorter research protocols and first-run comparisons before stepping up to the 20mg vial.

Key Research Areas

• Visceral Adipose Reduction — Studied specifically for reducing deep abdominal fat rather than total bodyweight
• Body Recomposition — Research focused on fat distribution rather than gross weight change
• GH/IGF-1 Axis — Stimulates endogenous GH release with downstream IGF-1 elevation
• Recovery Research — Downstream GH/IGF-1 effects studied in tissue repair and conditioning models
• Shorter-Protocol Format — 10mg vial size suitable for shorter research studies

Supplied as lyophilized powder at high purity, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.